ethyl-2,4,6-tri-isopropylbenzenesulphonate | 7253-78-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ethyl-2,4,6-tri-isopropylbenzenesulphonate
• 英文别名: 1,3,5-Triisopropyl-benzol-sulfonsaeure-(2)-aethylester；Ethyl 2,4,6-tri(propan-2-yl)benzenesulfonate
• CAS: 7253-78-3
• 化学式: C₁₇H₂₈O₃S
• 分子量: 312.474
• InChiKey: BPNGKKNDMBIPMR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  21
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.65
• 拓扑面积：
  51.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2,4,6-三异丙基苯磺酰氯 、 sodium ethanolate 以 乙醇 为溶剂， 生成 ethyl-2,4,6-tri-isopropylbenzenesulphonate
  参考文献：
  名称：

  Guthrie, R. D. (Gus); Thang, San, Australian Journal of Chemistry, 1987, vol. 40, # 12, p. 2133 - 2136

  摘要：

  DOI：

文献信息

• PROTEASOME INHIBITORS
  申请人：Macherla Venkat Rami Reddy

  公开号：US20090298906A1

  公开（公告）日：2009-12-03

  Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.

  本文披露了包含磺酸酯、酯或醚基团的化合物(I)。化合物(I)可以包含在药物组合物中，并可用于治疗和/或改善疾病或症状，如癌症、微生物疾病和/或炎症。
• Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery
  申请人：ADEKA CORPORATION

  公开号：US10734684B2

  公开（公告）日：2020-08-04

  Disclosed is a nonaqueous secondary battery having a nonaqueous electrolyte containing a lithium salt dissolved in an organic solvent, in which the positive electrode active material is preferably a manganese-containing, lithium transition metal oxide salt. The nonaqueous electrolyte contains at least one compound of general formula (1), preferably at least one compound of general formula (1′). The content of the compound of formula (1) or (1′) in the nonaqueous electrolyte is preferably 0.001 to 10 mass %. The symbols in formulae (1) and (1′) are as defined in the description.

  揭示了一种非水性二次电池，其非水性电解质中含有溶解在有机溶剂中的锂盐，其中正极活性材料最好是含锰的锂过渡金属氧化物盐。非水性电解质至少包含一个一般式（1）的化合物，最好至少包含一个一般式（1′）的化合物。在非水性电解质中，化合物的一般式（1）或（1′）的含量最好为0.001至10质量%。式（1）和（1′）中的符号如描述中所定义。
• Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
  申请人：Aay Naing

  公开号：US20100249096A1

  公开（公告）日：2010-09-30

  Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.

  本发明公开了式(I)的化合物及其药学上可接受的盐和溶剂化物。这些化合物是MEK抑制剂，可用于治疗增生性疾病，如癌症。本发明还公开了含有这些化合物的制药组合物，以及使用本发明的化合物和组合物治疗癌症的方法。
• Azetidines as MEK inhibitors for the treatment of proliferative diseases
  申请人：Exelixis, Inc.

  公开号：US07915250B2

  公开（公告）日：2011-03-29

  Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.

  本发明揭示了I式化合物及其药学上可接受的盐和溶剂化物。这些化合物是MEK抑制剂，可用于治疗增生性疾病，如癌症。本发明还揭示了包含这些化合物的制药组合物，以及使用本发明的化合物和组合物治疗癌症的方法。
• Notes- Organic Disulfides and Related Substances. II. 2,4,6-Triisopropylphenyl Disulfide, the 2,4,5-Isomer, and Related Compounds
  作者：D Pearson、Drury Caine、Lamar Field

  DOI：10.1021/jo01075a630

  日期：1960.5